Mesenchymal Stem Cells in the Treatment of COVID-19

BC Guo, KH Wu, CY Chen, WY Lin, YJ Chang… - International Journal of …, 2023 - mdpi.com
Since the emergence of the coronavirus disease 2019 (COVID-19) pandemic, many lives
have been tragically lost to severe infections. The COVID-19 impact extends beyond the …

Mesenchymal stem cells (MSCs) as a potential therapeutic strategy in COVID-19 patients: literature research

A Coelho, RD Alvites, MV Branquinho… - Frontiers in cell and …, 2020 - frontiersin.org
In 2019, an outbreak of an unknown coronavirus–SARS-CoV-2–responsible for COVID-19
disease, was first reported in China, and evolved into a pandemic of huge dimensions and …

Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications

L Chen, J Qu, FS Kalyani, Q Zhang, L Fan… - Cellular and Molecular …, 2022 - Springer
As a result of cross-species transmission in December 2019, the coronavirus disease 2019
(COVID-19) became a serious endangerment to human health and the causal agent of a …

Mesenchymal Stem Cells Therapy for COVID-19: From Basic Research to Clinical Trial

YC Tao, EQ Chen - Current Stem Cell Research & Therapy, 2024 - ingentaconnect.com
The novel pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
causes coronavirus disease 2019 (COVID-19), a serious challenge for human health. In …

Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19

S Yasamineh, HG Kalajahi, P Yasamineh… - Stem Cell Research & …, 2022 - Springer
The SARS-COV-2 virus has infected the world at a very high rate by causing COVID-19
disease. Nearly 507 million individuals have been infected with this virus, with …

Clinical consideration for mesenchymal stem cells in treatment of COVID-19

KH Wu, YH Chao, TF Weng, JP Li - Current Pharmaceutical …, 2022 - ingentaconnect.com
COVID-19, which has strongly affected the 21st century, is caused by severe acute
respiratory syndrome (SARS)-CoV-2. The emergence of viral variants has rendered even …

Mesenchymal stem cell-based COVID-19 therapy: bioengineering perspectives

N Karakaş, S Üçüncüoğlu, D Uludağ, BS Karaoğlan… - Cells, 2022 - mdpi.com
The novel pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
causes coronavirus disease 2019 (COVID-19). Mesenchymal stem cells (MSCs) are …

Challenges for mesenchymal stem cell-based therapy for COVID-19

C Li, H Zhao, B Wang - Drug Design, Development and Therapy, 2020 - Taylor & Francis
Abstract The coronavirus disease 2019 (COVID-19) global pandemic continues and antiviral
agents and vaccines are currently under investigation. Mesenchymal stem cell (MSC)-based …

Expediting Molecular Translational Approach of Mesenchymal Stem Cells in COVID-19 Treatment

V Balaji Easwaran, S Satarker… - Current Stem Cell …, 2023 - ingentaconnect.com
Coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) emerged in late 2019 with severe respiratory failure and organ …

[HTML][HTML] Mesenchymal stem cells and COVID-19: What they do and what they can do

E Abu-El-Rub, RR Khasawneh… - World journal of stem …, 2021 - ncbi.nlm.nih.gov
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or coronavirus disease
2019 (COVID-19) pandemic has exhausted the health systems in many countries with …